International Journal of Pharmaceutical Investigation

REVIEW ARTICLE
Year
: 2017  |  Volume : 7  |  Issue : 2  |  Page : 41--46

Compensation to clinical trial participants in India: A gap analysis


Mohd Urooj, Gulam Mohammed Husain, Mohammad Ahmed Khan, Munawwar Husain Kazmi 
 Department of Pharmacology, Central Research Institute of Unani Medicine, Under CCRUM, Ministry of AYUSH Government of India, Hyderabad, Telangana, India

Correspondence Address:
Mohd Urooj
Central Research Institute of Unani Medicine, Under CCRUM, Ministry of AYUSH Government of India, A. G. Colony Road Opp. ESI Hospital, Hyderabad - 500 038, Telangana
India

The recent amendments notified by the Government of India, for conducting clinical trial, is greatly appreciable as promoting safety and well-being of human subjects. These rules clearly state that medical management of injuries in clinical trials is mandatory, and clinical trial-related injury or death needs to be compensated over and above the medical management. These rules need to be reconsidered for simplification and better understanding of issues regarding compensation. There is a need of clarity at some points which should be discussed with all stakeholders for better understanding of current regulations. In our view, attention must also be given to academic investigators, during discussion to promote availability of cost-effective treatment in India.


How to cite this article:
Urooj M, Husain GM, Khan MA, Kazmi MH. Compensation to clinical trial participants in India: A gap analysis.Int J Pharma Investig 2017;7:41-46


How to cite this URL:
Urooj M, Husain GM, Khan MA, Kazmi MH. Compensation to clinical trial participants in India: A gap analysis. Int J Pharma Investig [serial online] 2017 [cited 2017 Sep 26 ];7:41-46
Available from: http://www.jpionline.org/article.asp?issn=2230-973X;year=2017;volume=7;issue=2;spage=41;epage=46;aulast=Urooj;type=0